Literature DB >> 25911550

B-cell receptor usage correlates with the sensitivity to CD40 stimulation and the occurrence of CD4+ T-cell clonality in chronic lymphocytic leukemia.

Nadja Zaborsky1, Claudia Holler2, Roland Geisberger2, Daniela Asslaber2, Franz Josef Gassner2, Viktoria Egger2, Josephina Piñón-Hofbauer2, Thomas Kocher2, Tanja Nicole Hartmann2, Richard Greil2, Alexander Egle2.   

Abstract

Entities:  

Keywords:  B-cell receptor usage; CD4 positive; CD40 stimulation; T-cell clonality; chronic lymphocytic leukemia

Mesh：

Substances：

Year:  2015        PMID： 25911550      PMCID： PMC5004431          DOI： 10.3324/haematol.2015.124719

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  9 in total

1.  Expansion of a CD8(+)PD-1(+) replicative senescence phenotype in early stage CLL patients is associated with inverted CD4:CD8 ratios and disease progression.

Authors:  Claudia Nunes; Ryan Wong; Malcolm Mason; Chris Fegan; Stephen Man; Chris Pepper
Journal:  Clin Cancer Res       Date:  2011-12-21       Impact factor: 12.531

2.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia.

Authors:  R N Damle; T Wasil; F Fais; F Ghiotto; A Valetto; S L Allen; A Buchbinder; D Budman; K Dittmar; J Kolitz; S M Lichtman; P Schulman; V P Vinciguerra; K R Rai; M Ferrarini; N Chiorazzi
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

3.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia.

Authors:  T J Hamblin; Z Davis; A Gardiner; D G Oscier; F K Stevenson
Journal:  Blood       Date:  1999-09-15       Impact factor: 22.113

4.  Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia.

Authors:  J Brice Weinberg; Alicia D Volkheimer; Youwei Chen; Bethany E Beasley; Ning Jiang; Mark C Lanasa; Daphne Friedman; Gina Vaccaro; Catherine W Rehder; Carlos M Decastro; David A Rizzieri; Louis F Diehl; Jon P Gockerman; Joseph O Moore; Barbara K Goodman; Marc C Levesque
Journal:  Am J Hematol       Date:  2007-12       Impact factor: 10.047

5.  Clinical effect of stereotyped B-cell receptor immunoglobulins in chronic lymphocytic leukaemia: a retrospective multicentre study.

Authors:  Panagiotis Baliakas; Anastasia Hadzidimitriou; Lesley-Ann Sutton; Eva Minga; Andreas Agathangelidis; Michele Nichelatti; Athina Tsanousa; Lydia Scarfò; Zadie Davis; Xiao-Jie Yan; Tait Shanafelt; Karla Plevova; Yorick Sandberg; Fie Juhl Vojdeman; Myriam Boudjogra; Tatiana Tzenou; Maria Chatzouli; Charles C Chu; Silvio Veronese; Anne Gardiner; Larry Mansouri; Karin E Smedby; Lone Bredo Pedersen; Kirsten van Lom; Véronique Giudicelli; Hana Skuhrova Francova; Florence Nguyen-Khac; Panagiotis Panagiotidis; Gunnar Juliusson; Lefteris Angelis; Achilles Anagnostopoulos; Marie-Paule Lefranc; Monica Facco; Livio Trentin; Mark Catherwood; Marco Montillo; Christian H Geisler; Anton W Langerak; Sarka Pospisilova; Nicholas Chiorazzi; David Oscier; Diane F Jelinek; Nikos Darzentas; Chrysoula Belessi; Frederic Davi; Richard Rosenquist; Paolo Ghia; Kostas Stamatopoulos
Journal:  Lancet Haematol       Date:  2014-11-03       Impact factor: 18.959

Review 6.  The significance of stereotyped B-cell receptors in chronic lymphocytic leukemia.

Authors:  Nikos Darzentas; Kostas Stamatopoulos
Journal:  Hematol Oncol Clin North Am       Date:  2013-04       Impact factor: 3.722

7.  Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug.

Authors:  Alan G Ramsay; Amy J Johnson; Abigail M Lee; Güllü Gorgün; Rifca Le Dieu; William Blum; John C Byrd; John G Gribben
Journal:  J Clin Invest       Date:  2008-07       Impact factor: 14.808

8.  Chemotherapy-induced augmentation of T cells expressing inhibitory receptors is reversed by treatment with lenalidomide in chronic lymphocytic leukemia.

Authors:  Franz J Gassner; Nadja Zaborsky; Daniel Neureiter; Michael Huemer; Thomas Melchardt; Alexander Egle; Stefan Rebhandl; Kemal Catakovic; Tanja N Hartmann; Richard Greil; Roland Geisberger
Journal:  Haematologica       Date:  2014-02-21       Impact factor: 9.941

9.  T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.

Authors:  John C Riches; Jeffrey K Davies; Fabienne McClanahan; Rewas Fatah; Sameena Iqbal; Samir Agrawal; Alan G Ramsay; John G Gribben
Journal:  Blood       Date:  2012-12-17       Impact factor: 22.113
  9 in total
  5 in total

1.  Ibrutinib Therapy Increases T Cell Repertoire Diversity in Patients with Chronic Lymphocytic Leukemia.

Authors:  Qingsong Yin; Mariela Sivina; Harlan Robins; Erik Yusko; Marissa Vignali; Susan O'Brien; Michael J Keating; Alessandra Ferrajoli; Zeev Estrov; Nitin Jain; William G Wierda; Jan A Burger
Journal:  J Immunol       Date:  2017-01-11       Impact factor: 5.422

2.  Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity.

Authors:  Benjamin L Lampson; Siddha N Kasar; Tiago R Matos; Elizabeth A Morgan; Laura Rassenti; Matthew S Davids; David C Fisher; Arnold S Freedman; Caron A Jacobson; Philippe Armand; Jeremy S Abramson; Jon E Arnason; Thomas J Kipps; Joshua Fein; Stacey Fernandes; John Hanna; Jerome Ritz; Haesook T Kim; Jennifer R Brown
Journal:  Blood       Date:  2016-05-31       Impact factor: 22.113

3.  CD1d expression on chronic lymphocytic leukemia B cells affects disease progression and induces T cell skewing in CD8 positive and CD4CD8 double negative T cells.

Authors:  Nadja Zaborsky; Franz Josef Gassner; Daniela Asslaber; Petra Reinthaler; Ursula Denk; Sabine Flenady; Josefina Piñón Hofbauer; Barbara Danner; Stefan Rebhandl; Andrea Harrer; Roland Geisberger; Richard Greil; Alexander Egle
Journal:  Oncotarget       Date:  2016-08-02

4.  TIGIT expressing CD4+T cells represent a tumor-supportive T cell subset in chronic lymphocytic leukemia.

Authors:  Kemal Catakovic; Franz Josef Gassner; Christoph Ratswohl; Nadja Zaborsky; Stefan Rebhandl; Maria Schubert; Markus Steiner; Julia Christine Gutjahr; Lisa Pleyer; Alexander Egle; Tanja Nicole Hartmann; Richard Greil; Roland Geisberger
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

5.  CD4+ T cells, but not non-classical monocytes, are dispensable for the development of chronic lymphocytic leukemia in the TCL1-tg murine model.

Authors:  T Kocher; D Asslaber; N Zaborsky; S Flenady; U Denk; P Reinthaler; M Ablinger; R Geisberger; J W Bauer; M Seiffert; T N Hartmann; R Greil; A Egle; J Piñón Hofbauer
Journal:  Leukemia       Date:  2015-11-02       Impact factor: 11.528
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.